Increasing trend of utilising active surveillance for Gleason Score 7 (3 + 4) prostate cancer.

Bernardino, Rui; Sayyid, Rashid K; Leão, Ricardo; Zlotta, Alexandre R; van der Kwast, Theodorus; Klotz, Laurence; Fleshner, Neil E

Bernardino, Rui; Sayyid, Rashid K; Leão, Ricardo; Zlotta, Alexandre R; van der Kwast, Theodorus; Klotz, Laurence; Fleshner, Neil E.

Afiliación

Bernardino R; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
Sayyid RK; Computational and Experimental Biology Group, NOVA Medical School, Faculdade de Ciências Médicas, Universidade NOVA de Lisboa, Lisbon, Portugal.
Leão R; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
Zlotta AR; Hospitais Cuf, Coimbra, Portugal.
van der Kwast T; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
Klotz L; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
Fleshner NE; Division of Urology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.

BJU Int ; 132(6): 638-640, 2023 12.

Article en En | MEDLINE | ID: mdl-37606994

Asunto(s)

Neoplasias de la Próstata; Espera Vigilante; Masculino; Humanos; Clasificación del Tumor; Próstata; Antígeno Prostático Específico

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Espera Vigilante Tipo de estudio: Screening_studies Límite: Humans / Male Idioma: En Revista: BJU Int Asunto de la revista: UROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google